Skip to content

Author

F. Sansi

We have 2 of 17 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

545. Targeting negative and cognitive symptoms in schizophrenia: discussion of novel preclinical and clinical findings with evenamide

Clinical findings from phase 2/3 trials with evenamide are interpreted in light of the results obtained with MAM model, and new analyses on the effect of evenamide on negative symptoms are presented to present new analyses on the effect of evenamide on negative symptoms.

R. Anand, A. Turolla, G. Chinellato et al. · 0 citations
Open access Sep 2026

526. Translating glutamate modulation into clinical advances for patients with treatment-resistant schizophrenia: challenges and updates from the ENIGMA-TRS phase 3 program

The goal is to generate reliable data supporting evenamide as an effective alternative for treating TRS, and to present challenges in the design and implementation of ENIGMA-TRS, the largest phase 3 clinical program ever designed for patients with TRS.

R. Anand, A. Turolla, G. Chinellato et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.